{"id":144498,"date":"2025-01-06T19:31:40","date_gmt":"2025-01-06T18:31:40","guid":{"rendered":"https:\/\/efecomunica.efe.com\/?p=144498"},"modified":"2025-01-07T11:52:20","modified_gmt":"2025-01-07T10:52:20","slug":"bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"Bright Peak Therapeutics to participate in 43rd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div>\n<p><span style=\"font-weight: 400;\">Statement issued by the company (Announcement)<\/span><\/p>\n<p>Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced that <strong>Fredrik Wiklund<\/strong>, Chief Executive Officer, will present at the 43<sup>rd<\/sup> Annual J.P. Morgan Healthcare Conference on Tuesday, January 14<sup>th<\/sup>, 2025, at 2:30 p.m. Pacific Time. The Company will also participate in 1-on-1 investor meetings during the conference.<\/p>\n<h2><strong>About Bright Peak Therapeutics<\/strong><\/h2>\n<p>Bright Peak Therapeutics is a clinical-stage biotechnology company pioneering multifunctional immunotherapies to treat cancer. Leveraging innovative protein engineering and a proprietary chemical protein synthesis and conjugation platform, Bright Peak is building a robust pipeline of first-in-class multifunctional molecules. The company&#8217;s lead program, BPT567, is a bifunctional PD1-IL18 immunoconjugate currently in Phase 1\/2a clinical trials. With headquarters in Basel, Switzerland, and San Diego, CA, Bright Peak is backed by top-tier healthcare investors. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nuHcUBzO9EXeNwNBdH8FbiZq49joIWpZB4FBT-jnxstsgA_oO4OHA5ngFXWajYunjvPXUfdFdAGvEFQY0YHls7QXg8_2JGW_SVH_7RQx27M=\" target=\"_blank\" rel=\"noopener\">www.brightpeaktx.com<\/a>.<\/p>\n<pre><strong>Contact:<\/strong>\r\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MaMq-Q8tgCnj25WpJrZ6j7wN_vD628q4XDvVz_4-MJWYCAy6pTFzOS8-gMwaWqKtpGlv35U6z3lKWfTG0K3J46r9RHZsrMZedQloddIi81A=\" target=\"_blank\" rel=\"noopener\">info@brightpeaktx.com<\/a><\/pre>\n<\/div>\n<p><i><span style=\"font-weight: 400;\">AGENCIA EFE S.A.U.,S.M.E. shall not be liable for any information contained in this message and assumes no responsibility towards third parties in relation to its contents, being expressly exempt from any liability that the author may have in relation to the information in question. Agencia EFE reserves the right to distribute the press release on the news wire, or to publish it on EFE Comunica.<\/span><\/i><\/p>\n<div>\n<p><img \/><br \/>\n<img \/><\/p>\n<\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Statement issued by the company (Announcement) Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced that Fredrik Wiklund, Chief Executive Officer, [&hellip;]<\/p>\n","protected":false},"author":198164071,"featured_media":48434,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[125518],"tags":[],"class_list":["post-144498","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bright Peak Therapeutics to participate in Conference Morgan<\/title>\n<meta name=\"description\" content=\"Bright Peak Therapeutics announced that Fredrik Wiklund, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bright Peak Therapeutics to participate in Conference Morgan","description":"Bright Peak Therapeutics announced that Fredrik Wiklund, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"EFE","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/person\/38c335f1ce4cd42430576ef5499343b8"},"headline":"Bright Peak Therapeutics to participate in 43rd Annual J.P. Morgan Healthcare Conference","datePublished":"2025-01-06T18:31:40+00:00","dateModified":"2025-01-07T10:52:20+00:00","mainEntityOfPage":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/"},"wordCount":229,"publisher":{"@id":"https:\/\/efecomunica.efe.com\/#organization"},"image":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","articleSection":["Globenewswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/","name":"Bright Peak Therapeutics to participate in Conference Morgan","isPartOf":{"@id":"https:\/\/efecomunica.efe.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","datePublished":"2025-01-06T18:31:40+00:00","dateModified":"2025-01-07T10:52:20+00:00","description":"Bright Peak Therapeutics announced that Fredrik Wiklund, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare.","breadcrumb":{"@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","contentUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","width":1200,"height":650,"caption":"El \u00edndice Moneyball de Squawka clasifica a los clubes de la Premier League tomando en cuenta las \u00faltimas cinco temporadas (incluida la 2025\/26)."},{"@type":"BreadcrumbList","@id":"https:\/\/efecomunica.efe.com\/en\/bright-peak-therapeutics-to-participate-in-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/efecomunica.efe.com\/"},{"@type":"ListItem","position":2,"name":"Bright Peak Therapeutics to participate in 43rd Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/efecomunica.efe.com\/#website","url":"https:\/\/efecomunica.efe.com\/","name":"EFE Comunica","description":"Contenidos para empresas","publisher":{"@id":"https:\/\/efecomunica.efe.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/efecomunica.efe.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/efecomunica.efe.com\/#organization","name":"EFE Comunica","url":"https:\/\/efecomunica.efe.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/logo\/image\/","url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2020\/12\/Logo-EFE-Comunica_png.png","contentUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2020\/12\/Logo-EFE-Comunica_png.png","width":1080,"height":486,"caption":"EFE Comunica"},"image":{"@id":"https:\/\/efecomunica.efe.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EFEComunicaAgenciaEFE","https:\/\/x.com\/EFEcomunica","https:\/\/www.linkedin.com\/showcase\/efecomunica"]},{"@type":"Person","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/person\/38c335f1ce4cd42430576ef5499343b8","name":"EFE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","caption":"EFE"},"sameAs":["http:\/\/efe.com"],"url":"https:\/\/efecomunica.efe.com\/en\/author\/efedesarrollo\/"}]}},"jetpack_featured_media_url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","jetpack_likes_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pcEg1r-BAC","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/144498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/users\/198164071"}],"replies":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/comments?post=144498"}],"version-history":[{"count":4,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/144498\/revisions"}],"predecessor-version":[{"id":144569,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/144498\/revisions\/144569"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/media\/48434"}],"wp:attachment":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/media?parent=144498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/categories?post=144498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/tags?post=144498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}